PRTA announced that BMS communicated that the FDA granted Fast Track Designation to BMS-986446, an anti-tau antibody in P2 for Alzheimer's disease.

Anti-microtubule binding region-tau antibody being investigated as a potential disease-modifying therapy to slow or delay progression of diseaseFast Track Designation recognizes the potential of ...

In this context, conductive foam serves as a key "electromagnetic pathway" connecting the battery module casing and the ...

Drug prices in the UK could rise amid 100 per cent tariffs on branded medicines, and pressure from US President Donald Trump ...

U.S. Customs and Border Protection officials detected cesium 137 in shipping containers of shrimp sent by PT Bahari Makmur Sejati to several U.S. ports. CBP officials flagged the potential ...

Bristol Myers Squibb (NYSE: BMY) will announce results for the third quarter of 2025 on Thursday, October 30, 2025. Company executives will review financial results with the investment community ...

Bristol Myers Squibb (NYSE: BMY) today announced an expansion of its direct-to-patient offerings, providing eligible U.S. patients with steeply discounted prices for Eliquis ® (apixaban) and Sotyktu ® ...

International officials say contaminated metal at an industrial site in Indonesia could be the source of radioactive material behind recalls of imported shrimp ...

Bristol Myers Squibb to Participate in the Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum ...

MG India gave us a tour of its EV battery assembly shop within the carmaker''''s manufacturing plant in Halol, Gujarat. Tap ...

Hoymiles has unveiled its ‘Hi Series’ in Germany. Featuring the HiFlow/ HiFlow Pro microinverters and the HiBattery AC micro ...